Paolo Cavazza's Net Worth
$23 Million
Estimate Recalculated May 2, 2024 04:05PM EST
Who is Paolo Cavazza?
Paolo Cavazza has an estimated net worth of $23 Million. This is based on reported shares across multiple companies, which include REGENERX BIOPHARMACEUTICALS INC, SOLIGENIX, INC., SCICLONE PHARMACEUTICALS INC, QUESTCOR PHARMACEUTICALS INC, and FENNEC PHARMACEUTICALS INC..
SEC CIK
Paolo Cavazza's CIK is 0001163608
Past Insider Trading and Trends
2005 was Paolo Cavazza's most active year for acquiring shares with 146 total transactions. Paolo Cavazza's most active month to acquire stocks was the month of April. 2006 was Paolo Cavazza's most active year for disposing of shares, totalling 34 transactions. Paolo Cavazza's most active month to dispose stocks was the month of November. 2007 saw Paolo Cavazza paying a total of $12,118,498.48 for 3,019,913 shares, this is the most they've acquired in one year. In 2012 Paolo Cavazza cashed out on 6,980,941 shares for a total of $36,649,924.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FENNEC PHARMACEUTICALS INC. (FENC) Snapshot price: $10
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.81% | 768K |
$6.25 | $4,800,000.00 | 3.99M |
Apr 30
| |||
Form 4
| +10.03% | 294.12K |
$8.50 | $2,499,977.50 | 3.23M |
Dec 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
QUESTCOR PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.95% | -2.20M |
$4.95 | -$10,890,000.00 | 4.91M |
Aug 13
| |||
Form 4
| -1.39% | -100.00K |
$4.91 | -$491,470.00 | 7.11M |
Jul 16
| |||
Form 4
| -0.43% | -31.34K |
$5.20 | -$162,957.60 | 7.21M |
Jul 2
| |||
Form 4
| -0.11% | -8.00K |
$5.20 | -$41,600.00 | 7.24M |
Jun 5 - Jun 6
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
$4.68 |
—
| 7.25M |
Nov 20
| |||
Form 4
|
—
|
0
|
$1.50 |
—
| 9.5M |
Dec 20
| |||
Form 4
| +39.28% | 690K |
$1.45 | $1,000,500.00 | 2.45M |
Dec 13
| |||
Form 4
| -100.00% | -1.27M |
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
∞
| 100K |
$0.65 | $65,000.00 | 100K |
Apr 13
| |||
Form 4
| +22.27% | 100K |
$0.71 | $71,380.00 | 549.1K |
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
∞
| 759.49K |
$0.64 | $489,113.49 | 759.49K |
Jan 12
| |||
Form 4
| -0.06% | -10.00K |
$0.84 | -$8,409.00 | 16.43M |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REGENERX BIOPHARMACEUTICALS INC (RGRXD) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
∞
| 1.5M |
$0.20 | $300,000.00 | 1.5M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +9.84% | 3.13M |
$0.06 | $188,020.86 | 34.99M |
Sep 27
| |||
Form 4
| +128.82% | 17.93M |
$0.23 | $4,124,744.79 | 31.86M |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 4
| +10.88% | 2.22M |
$0.27 | $600,000.21 | 22.65M |
Jan 5
| |||
Form 4
|
∞
| 240K |
—
|
—
| 240K |
May 21
| |||
Form 4
| +17.53% | 1.22M |
$0.82 | $999,999.84 | 8.18M |
Oct 8
| |||
Form 4
| +4.70% | 312.5K |
$0.40 | $125,000.00 | 6.96M |
Jun 2
| |||
Form 4
| +18.83% | 1.05M |
$0.57 | $599,999.67 | 6.64M |
Apr 13
| |||
Form 4
| +22.71% | 1.03M |
$1.45 | $1,499,998.90 | 5.59M |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +121.60% | 2.5M |
$1.00 | $2,500,000.00 | 4.56M |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +13.44% | 1.67M |
$1.80 | $2,999,998.80 | 14.07M |
Dec 21
| |||
Form 4
| +2.41% | 263.16K |
$1.50 | $394,737.00 | 11.18M |
Jul 14
| |||
Form 4
| +11.39% | 125K |
$2.80 | $350,000.00 | 1.22M |
May 26
| |||
Form 4
| +7.10% | 796.42K |
$2.81 | $2,237,954.25 | 12.01M |
Mar 6
| |||
Form 4
| +0.91% | 110K |
$3.20 | $352,000.00 | 12.2M |
Aug 1
| |||
Form 4
| +55.45% | 7.84M |
$2.64 | $11,699,997.64 | 21.97M |
Jun 11 - Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOLIGENIX, INC. (SNGX) Snapshot price: $0.604
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.12 |
—
| 293.51K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +25.09% | 11.54M |
$0.21 | $2,364,758.84 | 57.51M |
Jun 18
| |||
Form 4
| +9.49% | 3.95M |
$0.25 | $999,999.96 | 45.62M |
Sep 24
| |||
Form 4
| +150.00% | 25M |
$0.18 | $4,500,000.00 | 41.67M |
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCICLONE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -80.84% | -6.98M |
$5.25 | -$36,649,924.50 | 1.65M |
Apr 30
| |||
Form 4
| +0.44% | 28.6K |
$2.05 | $58,604.26 | 6.58M |
Jan 30
| |||
Form 4
| +0.01% | 400 |
$2.05 | $820.00 | 6.55M |
Jan 28
| |||
Form 4
| +0.56% | 36.29K |
$2.05 | $74,224.71 | 6.55M |
Jan 24 - Jan 25
| |||
Form 4
| +0.45% | 29.13K |
$2.01 | $58,629.86 | 6.52M |
Jan 22 - Jan 23
| |||
Form 4/A
| +0.00% | 200 |
$2.00 | $400.00 | 6.42M |
Jan 14
| |||
Form 4
| +0.49% | 63.33K |
$2.01 | $127,553.06 | 12.96M |
Jan 15 - Jan 16
| |||
Form 4
| +0.44% | 28.4K |
$2.00 | $56,782.40 | 6.42M |
Jan 11 - Jan 14
| |||
Form 4
| +0.86% | 54.64K |
$2.04 | $111,574.88 | 6.39M |
Nov 13
| |||
Form 4
| +0.27% | 17.36K |
$2.05 | $35,548.48 | 6.34M |
Nov 7 - Nov 8
| |||
Form 4
| +0.64% | 40.26K |
$2.05 | $82,361.73 | 6.32M |
Nov 5
| |||
Form 4
| +0.87% | 54.12K |
$2.05 | $110,885.71 | 6.28M |
Nov 1 - Nov 2
| |||
Form 4
| +0.40% | 25K |
$2.05 | $51,250.00 | 6.23M |
Oct 19
| |||
Form 4
| +0.67% | 41.27K |
$2.05 | $84,598.95 | 6.2M |
Oct 17 - Oct 18
| |||
Form 4
| +1.15% | 70K |
$2.06 | $143,950.00 | 6.16M |
Oct 15 - Oct 16
| |||
Form 4
| +0.40% | 24.34K |
$1.95 | $47,388.97 | 6.09M |
Oct 1 - Oct 2
| |||
Form 4
| +24.12% | 559.3K |
$2.50 | $1,398,250.00 | 2.88M |
Dec 15
| |||
Form 4
| +4.37% | 47.5K |
$2.50 | $118,750.00 | 1.13M |
Sep 15
| |||
Form 4
| +0.23% | 2.5K |
$2.50 | $6,250.00 | 1.09M |
Aug 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +26.47% | 226.9K |
$2.50 | $567,250.00 | 1.08M |
Jun 16
| |||
Form 4
| +6.15% | 85.1K |
$2.50 | $212,250.00 | 1.47M |
Jun 13 - Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30 - May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25 - May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17 - May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17 - Mar 20
| |||
Form 4
| +4.86% | 100K |
$2.63 | $259,981.90 | 2.16M |
Mar 14 - Mar 15
| |||
Form 4
| +0.56% | 44.3K |
$2.43 | $107,462.94 | 7.92M |
Feb 2
| |||
Form 4
| +0.83% | 64.7K |
$2.22 | $143,341.27 | 7.88M |
Jan 31
| |||
Form 4
| +0.45% | 34.64K |
$2.18 | $75,519.56 | 7.82M |
Dec 20
| |||
Form 4
| +1.25% | 95.73K |
$3.00 | $206,163.00 | 7.78M |
Dec 16 - Dec 19
| |||
Form 4
| +22.22% | 1.4M |
$4.98 | $6,960,181.79 | 7.69M |
Jun 17
| |||
Form 4
| +1.14% | 123.52K |
$4.50 | $552,514.79 | 10.93M |
Jun 15 - Jun 16
| |||
Form 4
| +1.21% | 181.55K |
$4.13 | $753,155.80 | 15.2M |
Jun 10 - Jun 13
| |||
Form 4
| +11.40% | 612K |
$2.50 | $1,530,000.00 | 5.98M |
Jun 6 - Jun 7
| |||
Form 4
| +0.13% | 6.9K |
$2.58 | $17,787.51 | 5.37M |
Jun 1
| |||
Form 4
| +2.88% | 150K |
$2.53 | $379,170.00 | 5.36M |
May 31
| |||
Form 4
| +1.96% | 100K |
$2.43 | $243,180.00 | 5.21M |
May 26
| |||
Form 4
| +3.02% | 150K |
$2.38 | $357,170.00 | 5.11M |
May 24 - May 25
| |||
Form 4
| +1.88% | 91.48K |
$2.45 | $223,695.00 | 4.96M |
May 20 - May 23
| |||
Form 4
| +0.80% | 38.52K |
$2.58 | $99,320.00 | 4.87M |
May 18 - May 19
| |||
Form 4
| +0.54% | 26.16K |
$2.55 | $66,702.90 | 4.83M |
May 13
| |||
Form 4
| +0.04% | 2.14K |
$2.55 | $5,462.10 | 4.81M |
May 12
| |||
Form 4
| +0.04% | 1.7K |
$2.53 | $4,302.87 | 4.81M |
May 11 - May 12
| |||
Form 4
| +0.29% | 14K |
$2.50 | $35,000.00 | 4.8M |
May 10
| |||
Form 4
| +0.71% | 33.8K |
$5.00 | $169,000.00 | 4.79M |
May 6
| |||
Form 4
| +0.38% | 17.87K |
$2.70 | $48,234.31 | 4.76M |
Apr 15 - Apr 18
| |||
Form 4
| +0.63% | 29.5K |
$2.79 | $82,177.40 | 4.74M |
Apr 14 - Apr 15
| |||
Form 4
| +0.92% | 33.11K |
$3.91 | $94,525.00 | 3.63M |
Mar 29 - Mar 30
| |||
Form 4
| +15.22% | 617.6K |
$5.05 | $3,098,000.00 | 4.68M |
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +0.56% | 22.4K |
$5.00 | $112,000.00 | 4.06M |
Mar 3
| |||
Form 4
| +0.50% | 20K |
$3.20 | $63,932.00 | 4.04M |
Feb 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +0.02% | 1K |
$5.00 | $5,000.00 | 4.02M |
Feb 17
| |||
Form 4
| +0.09% | 3.7K |
$7.50 | $27,750.00 | 4.01M |
Feb 14
| |||
Form 4
| +0.50% | 20K |
$3.40 | $68,000.00 | 4.01M |
Feb 10
| |||
Form 4
| +0.49% | 19.5K |
$3.51 | $68,393.91 | 3.99M |
Feb 7
| |||
Form 4
| +0.82% | 32.2K |
$3.25 | $104,761.56 | 3.97M |
Feb 3 - Feb 7
| |||
Form 4
| +0.70% | 27.3K |
$5.25 | $114,750.00 | 3.94M |
Jan 28 - Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.11% | 43K |
$5.00 | $215,000.00 | 3.91M |
Nov 19 - Dec 17
| |||
| No matching records found | |||||||||